On April 29, Juneyao Health (605388) released its 2024 annual report, reporting operating revenue of RMB 1.46 billion (approximately USD 201.7 million), a year-on-year decline of 10.8%. The company posted a net loss attributable to shareholders of RMB 29.12 million (approximately USD 4.02 million), down 150.6% year-on-year.
The report noted significant changes in business operations, particularly in the probiotic beverage segment. Revenue from probiotic foods rose 26.76% compared to 2023, and revenue from other beverages and food products grew 45.78%.
Although overall revenue growth was strong, the company remains in an investment phase, leading to increased costs and a corresponding decline in net profit compared to 2023. (Source: sohu.com)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE